Capsular polysaccharide adhesin antigen, preparation, purification and use
AssigneeThe Brigham and Women's Hospital, Inc.
InventorGerald B. Pier
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Brigham and Women's Hospital, Inc.
InventorGerald B. Pier
Estimating the term…
A substantially pure capsular exopolysaccharide adhesin of coagulaso-negative staphylococcal strains, and a general method to prepare such adhesins, are described. Vaccines composed of such adhesins, and uses of such adhesins to produce polyclonal and mono-clonal antibodies against such adhesins, are also disclosed. The adhesins are useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, and as a probe in selecting desirable polymeric medical materials. Such adhesin antibodies are useful in vivo to prevent infection by noso-comial coagulase-negative staphylococcal strains, in assays for the detection of such bacteria, in assays for the estimation of such adhesins in complex mixtures, and as an affinity chromatography matrix.
A vaccine against coagulase-negative Staphylococci comprising a pharmacologically acceptable non-toxic vehicle containing a substantially pure capsular polysaccharide adhesin antigen of Staphylococcus epidermidis that binds to polymeric material, wherein said adhesin antigen inhibits, at a concentration of about 0.1 mg/ml, binding to said polymeric material of at least about 50% of cells of Staphylococcus epidermidis RP-62A, RP-62NA or F-3248.
Dependencies are inferred from the claim text.